North America Bioinformatics Market Size, Share, Trends, Growth Drivers | Major Companies 2026 - Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc.

Leander, Texas and Tokyo, Japan - Jan.21.2026
As per DataM intelligence research report "The North America Bioinformatics Market is expected to grow at a high CAGR during the forecast period 2023-2030."

The North America bioinformatics market is growing rapidly with advances in genomics, proteomics, and data-driven life sciences research. Innovations in AI algorithms, cloud computing, and precision analytics enhance drug discovery and personalized medicine. Rising investment in biotechnology and research infrastructure is fueling market expansion.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/north-america-bioinformatics-market?prasad

North America Bioinformatics Market: Competitive Intelligence
Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific

In the North America Bioinformatics Market, Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS, BGI, and Eurofins Scientific collectively strengthen a sector that underpins genomic research, molecular diagnostics, and personalized medicine by providing advanced data analytics, sequencing platforms, and cloud-based computational solutions. These companies enable researchers, clinical laboratories, and pharmaceutical organizations to process, interpret, and visualize large-scale genomic and multi-omics datasets efficiently, accelerating discovery and therapeutic development. By integrating AI-driven analytics, scalable storage, and high-throughput sequencing support, they enhance data accuracy, reproducibility, and actionable insights, helping drive innovation in diagnostics, drug development, and precision healthcare. Their combined focus on interoperability, compliance, and performance reinforces the North America Bioinformatics Market as a cornerstone of modern life sciences and clinical research.

Individually and in combination, these firms' strengths create competitive differentiation and technological depth within the North America Bioinformatics Market by merging sequencing expertise, software platforms, and analytical innovation. Thermo Fisher Scientific Inc. and Illumina, Inc. provide cutting-edge sequencing and data acquisition technologies that feed high-quality genomic information into bioinformatics pipelines. Agilent Technologies, Inc. and QIAGEN offer integrated sample preparation, assay development, and bioinformatics tools that enhance workflow efficiency and data interpretation. SOPHiA GENETICS delivers AI-driven analytics platforms for clinical genomics, enabling actionable insights in diagnostics and precision medicine. BGI contributes high-throughput sequencing capabilities with bioinformatics integration for large-scale research projects, while Eurofins Scientific offers specialized data analysis services and validation for regulatory and clinical applications. Together, these companies propel the North America Bioinformatics Market forward by providing a comprehensive ecosystem that combines advanced sequencing, analytics, and interpretation, empowering research, diagnostics, and therapeutic innovation.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/north-america-bioinformatics-market?prasad

United States: Recent Industry Developments

✅ In January 2026, Illumina deployed automated bioinformatics platforms integrating AI-assisted genomic analysis and robotics-assisted data processing to accelerate research and clinical insights.

✅ In November 2025, Thermo Fisher Scientific invested $55 million in robotics-assisted AI-monitored bioinformatics platforms to enhance precision, throughput, and reproducibility.

✅ In August 2025, QIAGEN implemented automated AI-assisted genomic data workflows with robotics for high-throughput bioinformatics analysis.

✅ In June 2025, Bina Technologies deployed AI-monitored robotics-assisted bioinformatics platforms to standardize genomic data processing and improve efficiency.

Japan: Recent Industry Developments

✅ In January 2026, RIKEN deployed AI-assisted automated bioinformatics platforms, supported by $40 million investment, integrating robotics for genomic analysis, data curation, and workflow automation.

✅ In October 2025, Fujitsu Laboratories implemented robotics-assisted AI-monitored bioinformatics workflows for large-scale genomic data analysis.

✅ In July 2025, NEC Corporation introduced automated AI-assisted robotics-enabled platforms for bioinformatics research and clinical genomics.

✅ In April 2025, Hitachi Ltd deployed AI-monitored automated bioinformatics platforms with robotics to standardize genomic data processing.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=north-america-bioinformatics-market

Segment Covered in the North America Bioinformatics Market:
By Type
The market is segmented into bioinformatics software & services 65% and knowledge management tools 35%, with software & services dominating due to growing adoption of data analytics, genomics research, and AI-driven bioinformatics solutions. Knowledge management tools support collaboration, data storage, and workflow optimization in research and clinical settings. Rapid technological advancements and increasing data volume drive type-level growth.

By Application
Applications include genomics & drug development 40%, proteomics 25%, transcriptomics 20%, and others 15%, with genomics & drug development dominating due to high demand for personalized medicine, gene therapy research, and pharmaceutical R&D. Proteomics and transcriptomics are increasingly adopted for biomarker discovery and functional analysis. Emerging applications in metabolomics and systems biology support growth.

By End-User
End-users comprise research & academic institutes 35%, biotech & pharmaceutical companies 30%, clinical research organizations 25%, and others 10%, with research institutes leading due to heavy adoption for genomics research, molecular modeling, and computational biology. Biotech and pharmaceutical companies leverage bioinformatics for drug discovery and precision medicine. CROs adopt solutions for clinical trial data analysis. Increasing investment in life sciences and R&D supports end-user growth.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.